Allscripts Healthcare Solutions (NASDAQ: MDRX) and Complete Genomics (NASDAQ:GNOM) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their risk, dividends, valuation, institutional ownership, profitability, earnings and analyst recommendations.
Earnings & Valuation
This table compares Allscripts Healthcare Solutions and Complete Genomics’ revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Allscripts Healthcare Solutions||$1.81 billion||1.29||-$152.60 million||($1.09)||-11.82|
Complete Genomics has lower revenue, but higher earnings than Allscripts Healthcare Solutions. Allscripts Healthcare Solutions is trading at a lower price-to-earnings ratio than Complete Genomics, indicating that it is currently the more affordable of the two stocks.
This table compares Allscripts Healthcare Solutions and Complete Genomics’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Allscripts Healthcare Solutions||-10.88%||7.36%||2.19%|
This is a breakdown of recent ratings and recommmendations for Allscripts Healthcare Solutions and Complete Genomics, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Allscripts Healthcare Solutions||1||4||12||0||2.65|
Allscripts Healthcare Solutions currently has a consensus target price of $16.22, indicating a potential upside of 25.92%. Given Allscripts Healthcare Solutions’ higher possible upside, equities research analysts plainly believe Allscripts Healthcare Solutions is more favorable than Complete Genomics.
Allscripts Healthcare Solutions beats Complete Genomics on 6 of the 8 factors compared between the two stocks.
About Allscripts Healthcare Solutions
Allscripts Healthcare Solutions, Inc. (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions. The Population Health segment includes the sale of health management and coordinated care solutions, which focus on hospitals, health systems, other care facilities and accountable care organizations (ACOs). The Netsmart segment provides software and technology solutions to the health and human services industry, which includes behavioral health, addiction treatment, intellectual and developmental disability services, child and family services and public health segments, as well as to post-acute home care organizations.
About Complete Genomics
Complete Genomics, Inc. is a life sciences company that has developed and commercialized a deoxyribonucleic acid (DNA) sequencing platform. Its complete genomics analysis platform (CGA) Platform, combines its human genome sequencing technology with its advanced informatics and data management software and its end-to-end, outsourced service model to provide its customers with data that is ready to be used for genome-based research. Its genome sequencing center combines a high-throughput sample preparation facility, a collection of its high-throughput sequencing instruments and a large- scale data center. Its customers include some of the global academic and government research centers and biopharmaceutical companies. Effective March 18, 2013, BGI-Shenzhen announced that through its wholly-owned subsidiary, Beta Acquisition Corporation, it has completed the acquisition of the Company.
Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.